The Mystery of High-density Lipoprotein: Quantity or Quality? Update on Therapeutic Strategies

The Mystery of High-density Lipoprotein: Quantity or Quality? Update on Therapeutic Strategies

This review summarizes the data challenging the concept that cardiovascular protection through high-density lipoprotein (HDL) is only associated with its serum concentration. This conventional impression about its protective role now appears obsolete. New aspects of its mechanisms are revealed and n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Reviews in cardiovascular medicine 2015, Vol.16 (1), p.9-19
Hauptverfasser: Katsi, Vasiliki, Kallistratos, Manolis S, Pavlidis, Antonios N, Karpettas, Nikos, Skoumas, Ioannis, Pavleros, Nikonas, Manolis, Athanasios J, Pitsavos, Christos, Tousoulis, Dimitris, Stefanadis, Christodoulos, Kallikazaros, Ioannis
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This review summarizes the data challenging the concept that cardiovascular protection through high-density lipoprotein (HDL) is only associated with its serum concentration. This conventional impression about its protective role now appears obsolete. New aspects of its mechanisms are revealed and novel therapeutic strategies are based on them. However, data from long-term cost-effectiveness studies of treating HDL are still needed. There is a need for biomarkers that represent the functional characteristics of HDL in order to better quantify the total cardiovascular risk.
ISSN:1530-6550
DOI:10.3909/ricm0719